Chinyama C N, Davies J D
Regional Breast Pathology Unit, University of Bristol, Southmead Hospital, UK.
Histopathology. 1996 Dec;29(6):533-9. doi: 10.1046/j.1365-2559.1996.d01-535.x.
A retrospective histopathological study was undertaken to determine the prevalence of mucin filled ducts and their associated mucinous proliferation in 962 breast cancers and 335 benign lesions. A total of 38 (3%) cases with mucin filled ducts was identified and 27 (2%) of these showed mucin extravasation into the adjacent stroma, changes characteristic of mucocoele-like lesions. This constitutes the largest series reported to date. Of the mucocoele-like lesions 12 were prototypic screen-detected cases: 11 of which were mammographically detected on account of suspicious microcalcification and eight cases (67%) exhibited mucinous atypical ductal hyperplasia without overt malignancy. A further 12 mucocoele-like lesions were incidental findings in screen-detected (11) and symptomatic (one) cancers, the majority of which were invasive ductal carcinomas of no special type. In six of these cases (50%), mucinous atypical ductal hyperplasia or ductal carcinoma in situ was present. Thirty mucinous carcinomas constituted 3% of all cancers and three cases had associated mucocoele-like lesions. Mucinous atypical ductal hyperplasia or ductal carcinoma in situ was also associated with 11 cases of mucinous carcinoma. In six mucinous carcinomas, amorphous microcalcification with a similar appearance to that of benign mucocoele-like lesions was identified in the mucin, suggesting a possible link between the two lesions. Mucin-filled ducts or mucocoele-like lesions were almost twice as frequent in screen-detected as in symptomatic lesions. The presence of mucinous atypical ductal hyperplasia in screen-detected mucocoele-like lesions, a decade earlier than the peak of mucinous carcinoma, is a possible risk factor for subsequent invasive malignancy. Mucin-filled ducts, mucocoele-like lesions, mucinous atypical ductal hyperplasia or ductal carcinoma in situ and mucinous carcinoma may represent different stages of the same disease process. Our findings suggest that patients with mucin-filled ducts of mucocoele-like lesions merit close follow-up.
开展了一项回顾性组织病理学研究,以确定962例乳腺癌和335例良性病变中黏液填充导管及其相关黏液性增殖的患病率。共识别出38例(3%)有黏液填充导管的病例,其中27例(2%)显示黏液外渗至邻近间质,这是黏液囊肿样病变的特征性改变。这是迄今为止报道的最大系列病例。在黏液囊肿样病变中,12例为典型的筛查发现病例:其中11例因可疑微钙化在乳腺钼靶检查中被发现,8例(67%)表现为黏液性非典型导管增生且无明显恶性特征。另外12例黏液囊肿样病变是在筛查发现的癌症(11例)和有症状的癌症(1例)中偶然发现的,其中大多数为非特殊类型的浸润性导管癌。在这些病例中的6例(50%)存在黏液性非典型导管增生或导管原位癌。30例黏液癌占所有癌症的3%,3例伴有黏液囊肿样病变。黏液性非典型导管增生或导管原位癌也与11例黏液癌相关。在6例黏液癌中,在黏液中发现了与良性黏液囊肿样病变外观相似的无定形微钙化,提示这两种病变之间可能存在联系。筛查发现的黏液填充导管或黏液囊肿样病变的频率几乎是有症状病变的两倍。在筛查发现的黏液囊肿样病变中存在黏液性非典型导管增生,比黏液癌的发病高峰早十年,这可能是随后发生浸润性恶性肿瘤的一个危险因素。黏液填充导管、黏液囊肿样病变、黏液性非典型导管增生或导管原位癌以及黏液癌可能代表同一疾病过程的不同阶段。我们的研究结果表明,患有黏液填充导管或黏液囊肿样病变的患者值得密切随访。